MedTrace Logo

Clinical Study Evaluating the Safety of a New Catheter for Urinary Intermittent Catheterization in Self Catheterized Patients

NCT02911051 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2018-01-25

No results posted yet for this study

Summary

The clinical study evaluates the safety of a new catheter for Urinary Intermittent Catheterisation in self catheterized patients

Conditions

  • Intermittent Urethral Catheterization

Interventions

DEVICE

Actreen Hydrolite Cath

Depending of the use of the self catheterized patient could be 4 to 6 Actreen Hydrolite Cath per day

Sponsors & Collaborators

  • BBraun Medical SAS

    lead INDUSTRY

Principal Investigators

  • Chartier-Kastler Emmanuel · Hôspital Raymond Poincaré - Garches

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-02
Primary Completion
2017-05-03
Completion
2017-05-03

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02911051 on ClinicalTrials.gov